NO20092340L - Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast - Google Patents
Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeastInfo
- Publication number
- NO20092340L NO20092340L NO20092340A NO20092340A NO20092340L NO 20092340 L NO20092340 L NO 20092340L NO 20092340 A NO20092340 A NO 20092340A NO 20092340 A NO20092340 A NO 20092340A NO 20092340 L NO20092340 L NO 20092340L
- Authority
- NO
- Norway
- Prior art keywords
- rvp2
- yeast
- fish
- svp
- pancreatic necrosis
- Prior art date
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title abstract 5
- 239000002245 particle Substances 0.000 title abstract 3
- 101900217743 Infectious pancreatic necrosis virus Capsid protein VP2 Proteins 0.000 title 1
- 241000710921 Infectious pancreatic necrosis virus Species 0.000 abstract 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract 4
- 241000251468 Actinopterygii Species 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 230000003612 virological effect Effects 0.000 abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 208000009663 Acute Necrotizing Pancreatitis Diseases 0.000 abstract 1
- 108090000565 Capsid Proteins Proteins 0.000 abstract 1
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 abstract 1
- 206010058096 Pancreatic necrosis Diseases 0.000 abstract 1
- 241000277331 Salmonidae Species 0.000 abstract 1
- 238000009360 aquaculture Methods 0.000 abstract 1
- 244000144974 aquaculture Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000000234 capsid Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 241001507086 salmonid fish Species 0.000 abstract 1
- 230000009269 systemic vascular permeability Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/045—Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87590106P | 2006-12-20 | 2006-12-20 | |
| PCT/US2007/087942 WO2008140610A2 (fr) | 2006-12-20 | 2007-12-18 | Antigénicité des particules sub-virales du virus vp2 de la nécrose pancréatique infectieuse exprimées dans la levure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20092340L true NO20092340L (no) | 2009-08-25 |
Family
ID=40002819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20092340A NO20092340L (no) | 2006-12-20 | 2009-06-18 | Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8221767B2 (fr) |
| CA (1) | CA2673355A1 (fr) |
| GB (1) | GB2477712A (fr) |
| NO (1) | NO20092340L (fr) |
| WO (1) | WO2008140610A2 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| DK1973406T3 (da) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corp | Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform |
| JP5285617B2 (ja) | 2006-12-18 | 2013-09-11 | アドバンスド バイオニュートリション コーポレーション | 生きたプロバイオティクスを含む乾燥食物製品 |
| GB2477712A (en) | 2006-12-20 | 2011-08-17 | Advanced Bionutrition Corp | Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast |
| US7998502B2 (en) | 2008-03-24 | 2011-08-16 | Advanced Bionutrition Corp. | Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| US8778384B2 (en) | 2008-03-24 | 2014-07-15 | Advanced Bionutrition Corporation | Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals |
| CA2756883C (fr) | 2009-03-27 | 2018-01-09 | Advanced Bionutrition Corp. | Vaccins microparticulaires utilisables pour proceder a une vaccination et a des rappels par voie orale ou nasale chez les animaux, dont les poissons |
| RU2567668C2 (ru) | 2009-05-26 | 2015-11-10 | Эдванст Бионутришн Корпорейшн | Стабильная сухая порошкообразная композиция, содержащая биологически активные микроорганизмы и/или биоактивные материалы, и способ ее изготовления |
| US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
| NZ601017A (en) | 2010-01-28 | 2014-07-25 | Advanced Bionutrition Corp | Dry glassy composition comprising a bioactive material |
| RS57588B1 (sr) | 2010-08-13 | 2018-11-30 | Advanced Bionutrition Corp | Supstanca za stabilizaciju bioloških materijala za suvo skladištenje |
| WO2014008475A2 (fr) * | 2012-07-05 | 2014-01-09 | The Ohio State University | Compositions et procédés associés à des vaccins viraux |
| GB201400311D0 (en) * | 2014-01-08 | 2014-02-26 | Aqua Gen As | Treating Susceptibility |
| WO2016005796A1 (fr) * | 2014-07-11 | 2016-01-14 | Fundacion Fraunhofer Chile Research | Agent avec des propriétés antivirales pour la prévention ou le traitement d'individus exposés à un virus de la famille des birnavirus |
| WO2017019273A1 (fr) | 2015-07-29 | 2017-02-02 | Advanced Bionutrition Corporation | Compositions probiotiques sèches stables pour des utilisations diététiques |
| CN107779458B (zh) * | 2016-08-29 | 2023-06-20 | 中国科学院上海巴斯德研究所 | 一种酵母细胞表达的狂犬病毒的病毒样颗粒及其制备方法 |
| WO2018209167A1 (fr) * | 2017-05-12 | 2018-11-15 | Ohio State Innovation Foundation | Compositions vaccinales contre le virus de la nécrose pancréatique infectieuse (ipnv) |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60143810D1 (de) | 2000-11-11 | 2011-02-17 | Univ Aberdeen | Vakzine gegen ipnv die aus hefezellen isoliert werden |
| ATE400189T1 (de) | 2001-03-23 | 2008-07-15 | Advanced Bionutrition Corp | Abgabe von mitteln zur krankheitskontrolle in aquakultur unter verwendung von bioaktive proteine enthaltender hefe |
| US6936256B2 (en) * | 2001-08-10 | 2005-08-30 | University Of Maryland Biotechnology Institute | Sub-unit vaccine for infectious pancreatic necrosis virus |
| WO2003017780A1 (fr) | 2001-08-27 | 2003-03-06 | Advanced Bionutrition Corporation | Apport de produits de lutte contre les maladies en aquaculture et agriculture au moyen d'aliments nutritionnels contenant des proteines bioactives produites par des virus |
| US7550647B2 (en) | 2001-09-14 | 2009-06-23 | Advanced Bionutrition | Transfected shrimp as production systems for therapeutic proteins |
| US7396548B2 (en) | 2002-03-19 | 2008-07-08 | Advanced Bionutrition Corporation | Microalgal feeds containing arachidonic acid and their production and use |
| WO2003089579A2 (fr) | 2002-04-15 | 2003-10-30 | Advanced Bionutrition Corporation | Incorporation de bacteries anaerobiques dans une formulation alimentaire |
| WO2003103692A1 (fr) | 2002-06-11 | 2003-12-18 | Moti Harel | Enrichissement de zooplancton avec des probionts et des prebionts et leurs utilisations |
| US20060121468A1 (en) | 2002-06-26 | 2006-06-08 | Allnutt F C T | Viruses and virus-like particles for multiple antigen and target display |
| JP4731907B2 (ja) | 2002-09-16 | 2011-07-27 | アドバンスド バイオニュートリション コーポレーション | 受動免疫のための蛋白質およびペプチド発現 |
| JP2006508651A (ja) | 2002-10-24 | 2006-03-16 | アドバンスド バイオニュートリション コーポレーション | エビおよびその生産 |
| NZ539900A (en) | 2002-11-07 | 2008-03-28 | Advanced Bionutrition Corp | Nutraceuticals and method of feeding aquatic animals |
| EP1578191A4 (fr) | 2002-11-14 | 2008-10-29 | Advanced Bionutrition Corp | Nourriture adaptee pour la culture de rotiferes, de larves de crevettes et d'autres organismes filtreurs marins |
| WO2004080196A2 (fr) | 2003-03-07 | 2004-09-23 | Advanced Bionutrition Corporation | Preparation d'aliments pour animaux terrestres et aquatiques |
| AU2005213981A1 (en) | 2004-02-06 | 2005-09-01 | Advanced Bionutrition Corporation | RNA-mediated interference to control disease in terrestrial and aquaculture animals |
| US7973148B2 (en) | 2004-04-15 | 2011-07-05 | Advanced Bionutrition Corporation | Crustacean expression vector |
| EP1750674A4 (fr) | 2004-05-27 | 2012-05-23 | Advanced Bionutrition Corp | Microparticules pour administration orale |
| CN101227900A (zh) | 2005-05-11 | 2008-07-23 | 高级生物营养公司 | 稳定形式的鱼油 |
| WO2007075988A2 (fr) | 2005-12-21 | 2007-07-05 | Advanced Bionutrition Corporation | Detection non invasive de virus frappant les poissons au moyen d'une pcr en temps reel |
| DK1973406T3 (da) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corp | Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform |
| WO2007084500A2 (fr) | 2006-01-13 | 2007-07-26 | Advanced Bionutrition Corporation | Système de production par capture par pulvérisations continues |
| BRPI0710665A2 (pt) | 2006-04-03 | 2011-08-16 | Advanced Bionutrition Corp | formulações de ração contendo ácido docosa-hexaenóico |
| JP5285617B2 (ja) | 2006-12-18 | 2013-09-11 | アドバンスド バイオニュートリション コーポレーション | 生きたプロバイオティクスを含む乾燥食物製品 |
| GB2477712A (en) | 2006-12-20 | 2011-08-17 | Advanced Bionutrition Corp | Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast |
-
2007
- 2007-12-18 GB GB0912467A patent/GB2477712A/en not_active Withdrawn
- 2007-12-18 WO PCT/US2007/087942 patent/WO2008140610A2/fr active Application Filing
- 2007-12-18 US US12/519,991 patent/US8221767B2/en not_active Expired - Fee Related
- 2007-12-18 CA CA 2673355 patent/CA2673355A1/fr not_active Abandoned
-
2009
- 2009-06-18 NO NO20092340A patent/NO20092340L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008140610A2 (fr) | 2008-11-20 |
| WO2008140610A9 (fr) | 2009-04-16 |
| US8221767B2 (en) | 2012-07-17 |
| GB0912467D0 (en) | 2009-08-26 |
| CA2673355A1 (fr) | 2008-11-20 |
| GB2477712A (en) | 2011-08-17 |
| US20100092521A1 (en) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20092340L (no) | Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast | |
| Aires et al. | Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells | |
| Xu et al. | Superior protection conferred by inactivated whole virus vaccine over subunit and DNA vaccines against salmonid alphavirus infection in Atlantic salmon (Salmo salar L.) | |
| Vaseeharan et al. | Shrimp vaccination trials with the VP292 protein of white spot syndrome virus | |
| CN103319604B (zh) | 一种人轮状病毒△vp8*亚单位重组蛋白及其应用 | |
| ES2723776T3 (es) | Nuevas cepas de rotavirus humano y vacunas | |
| Allnutt et al. | Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast | |
| Zhang et al. | Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis | |
| MY163972A (en) | Attenuated recombinant newcastle disease virus and vaccine containing the same | |
| Dhar et al. | Expression of a foreign epitope on infectious pancreatic necrosis virus VP2 capsid protein subviral particle (SVP) and immunogenicity in rainbow trout | |
| CN102465144A (zh) | 柯萨奇病毒a16型病毒样颗粒疫苗 | |
| Changotra et al. | Rotavirus virus‐like particles (RV‐VLPs) vaccines: An update | |
| NZ589755A (en) | Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same | |
| Kim et al. | Protection of olive flounder, Paralichthys olivaceus, against viral hemorrhagic septicemia virus (VHSV) by immunization with NV gene-knockout recombinant VHSV | |
| Guo et al. | Self-assembly of virus-like particles of rabbit hemorrhagic disease virus capsid protein expressed in Escherichia coli and their immunogenicity in rabbits | |
| CN103304642B (zh) | 猪轮状病毒δvp8*亚单位重组蛋白及其应用 | |
| Zhou et al. | Protective immunity of a Pichia pastoris expressed recombinant iridovirus major capsid protein in the Chinese giant salamander, Andrias davidianus | |
| Wi et al. | Protective immunity against nervous necrosis virus in convict grouper Epinephelus septemfasciatus following vaccination with virus-like particles produced in yeast Saccharomyces cerevisiae | |
| CN110904153A (zh) | 表达非洲猪瘟病毒p12或p17蛋白的重组猪繁殖与呼吸综合征病毒的构建方法及其应用 | |
| WO2006113528A3 (fr) | Procede pour exprimer un antigene de surface de virus de l'hepatite b afin de preparer un vaccin | |
| WO2009014782A3 (fr) | Production améliorée et assemblage in vivo de particules icosaédriques solubles recombinées analogues à un virus | |
| CN101302527A (zh) | 重排噬菌体e基因、含有该基因的打孔质粒载体及其应用 | |
| Wang et al. | An optimized, highly efficient, self-assembled, subvirus-like particle of infectious bursal disease virus (IBDV) | |
| TWI674109B (zh) | 包括類病毒顆粒及新型佐劑之禽流感疫苗組合物 | |
| CN102827846A (zh) | 重组柯萨奇病毒b3型病毒样颗粒的制备方法及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |